Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > CPIX > Summary

Cumberland Pharmaceuticals, Inc.
(CPIX)

11.52USD   Up0.11 (0.96%)   
At 2:30AM IST
 Cumberland Pharmaceuticals, Inc. (NasdaqNM:CPIX) Delayed quote data 
[Chart]
1d  5d  3m  6m 
Last Trade: 11.52USD
Trade Time:2:30AM IST
Change:Up0.11 (0.96%)
Prev Close:11.41
Open:11.47
Bid:9.62 x 100
Ask:N/A
1y Target Est:20.67
Day's Range:11.30 - 11.66
52wk Range:11.30 - 17.75
Volume:33,737
Avg Vol (3m):41,384.1
Market Cap:231.94M
P/E (ttm):50.31
EPS (ttm):0.23
Div & Yield:N/A (N/A%)
Add CPIX to Portfolio   Download Data

HEADLINES

 
•Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort - PR Newswire  - Wed, Jan 20
•After A Sluggish Year, VCs Eye Improvement - Investor's Business Daily  - Sat, Jan 9
•Caldolor(R) Data to Be Presented During Critical Care Conference in Miami Beach, Florida on January 12, 2010 - PR Newswire  - Wed, Jan 6
•The Worst IPOs Of 2009 - Investopedia  - Wed, Dec 16
•2009 Year End Strategy: Look at CEFs and IPOs - Seeking Alpha  - Wed, Dec 16
•Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study - PR Newswire  - Tue, Dec 15
•Worst IPOs of 2009: Biggest Stock Flops - TheStreet.com  - Tue, Dec 15
•Cumberland Pharma signs South Korea Caldolor deal - AP  - Wed, Dec 9
•Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea - PR Newswire  - Wed, Dec 9
•New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting - PR Newswire  - Thu, Dec 3
•Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems - PR Newswire  - Tue, Dec 1
» More Headlines for CPIX...

ANALYST

 
EPS Est (next year) (Dec-09) :0.20
EPS Est (in 2 years) (Dec-10) :0.48
Avg Rec (current)*:1.5
PEG Ratio:0.95
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Cumberland Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets.

» Full Company Profile